| __timestamp | Alkermes plc | AstraZeneca PLC |
|---|---|---|
| Wednesday, January 1, 2014 | 199905000 | 13324000000 |
| Thursday, January 1, 2015 | 311558000 | 11451000000 |
| Friday, January 1, 2016 | 374130000 | 9739000000 |
| Sunday, January 1, 2017 | 421578000 | 10543000000 |
| Monday, January 1, 2018 | 526408000 | 10362000000 |
| Tuesday, January 1, 2019 | 599449000 | 11848000000 |
| Wednesday, January 1, 2020 | 538827000 | 11693000000 |
| Friday, January 1, 2021 | 560977000 | 15680000000 |
| Saturday, January 1, 2022 | 605747000 | 18955000000 |
| Sunday, January 1, 2023 | 689751000 | 18025000000 |
| Monday, January 1, 2024 | 645238000 | 20532000000 |
Cracking the code
In the competitive world of pharmaceuticals, operational efficiency is key. This analysis compares the Selling, General, and Administrative (SG&A) expenses of AstraZeneca PLC and Alkermes plc from 2014 to 2023. AstraZeneca, a global leader, consistently outpaces Alkermes in SG&A spending, reflecting its expansive operations. In 2022, AstraZeneca's SG&A expenses were nearly 30 times higher than Alkermes, highlighting its vast market reach and operational scale. However, Alkermes shows a steady growth trend, with a 245% increase in SG&A expenses over the decade, indicating its strategic expansion efforts. This data provides a fascinating insight into how these companies allocate resources to maintain their competitive edge. As the pharmaceutical landscape evolves, monitoring these expenses can offer clues about future strategies and market positioning.
Breaking Down SG&A Expenses: Johnson & Johnson vs Alkermes plc
Comparing SG&A Expenses: Merck & Co., Inc. vs AstraZeneca PLC Trends and Insights
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Bristol-Myers Squibb Company
AstraZeneca PLC or Bio-Techne Corporation: Who Manages SG&A Costs Better?
AstraZeneca PLC or Alkermes plc: Who Leads in Yearly Revenue?
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: AstraZeneca PLC vs PTC Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: AstraZeneca PLC vs ImmunityBio, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Intra-Cellular Therapies, Inc. and Alkermes plc
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Alkermes plc
Comparing SG&A Expenses: Alkermes plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Comparing SG&A Expenses: Alkermes plc vs Evotec SE Trends and Insights